Meeting Programme

Dr Christine Faulkner (Oxford Brookes University)

Dr Santanu Datta (Cellworks)

Dr Ashwani Pareek (JNU, New Delhi)

Prof A S Raghavendra (University of Hyderabad)

Dr Anu Raghunathan (National Chemical Laboratory, Pune)

etiology is difficult to fathom due to multi-factorial emergent responses of the human system. Patients of such diseases would benefit highly from a personalized and individualized approach for treatment. Constraints-based flux balance models seem to provide such a platform for data integration and analysis of complex diseases. The focus of this talk is the development and analysis of tissue specific models for cancer. Global microarray gene expression data is used to develop cell-line and patient models for lung cancer using from legacy data using the genome scale model of human metabolism, Recon1 as the basis. The paradigm for metabolic systems biology as applied to lung cancer will be discussed in the context of computing the cancer phenotype. The predictions of clinical models using tissue data and blood data will be compared to the classical cell line models. Integration of results of routine blood work, specialized clinical tests like PET (Positron Emission Tomography) scans allow for better prognosis but also fundamental understanding of the disease. The challenge of such a task in the context of flux balance metabolic models for predictive differentiation of progressive disease states and their ability to predict outcomes will also be discussed.